NDC 0713-0937
cevimeline hydrochloride
Cevimeline Hydrochloride
cevimeline hydrochloride is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Cevimeline Hydrochloride.
| Product ID | 0713-0937_f183f958-57f5-ea10-e053-2995a90a5ead |
| NDC | 0713-0937 |
| Product Type | Human Prescription Drug |
| Proprietary Name | cevimeline hydrochloride |
| Generic Name | Cevimeline Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2023-01-03 |
| Marketing Category | NDA / |
| Application Number | NDA020989 |
| Labeler Name | Cosette Pharmaceuticals, Inc. |
| Substance Name | CEVIMELINE HYDROCHLORIDE |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |